Skip to main content
SpringerLink
Log in

Management of Thalassemia: Blood and Beyond

  • Invited Commentary
  • Published:
Indian Pediatrics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Cooley T, Lee P. A series of cases of splenomegaly in children with anemia and peculiar bone changes. Trans Am Pediatr Soc. 1925;37:29–30.

    Google Scholar 

  2. Mukherji M. Cooley’s anaemia (erythroblastic or Mediterranean anaemia). Indian J Pediatr. 1938;5:1–7.

    Article  Google Scholar 

  3. Coelho C. Erythroblastic anemia- Cooley’s anemia. Med Bull Bombay. 1939;7:291–3.

    Google Scholar 

  4. Moirangthem A, Phadke S. Socio-demographic profile and economic burden of treatment of transfusion dependent thalassemia. Indian J Pediatr. 2018;85:102–7.

    Article  Google Scholar 

  5. Bhat KV, Sharma R, Sharma S, et al. Vitamin C deficiency and oxidant levels in children with transfusion-dependent β-thalassemia. Indian Pediatr. 2021;58:631–4.

    PubMed  Google Scholar 

  6. Singh P, Samaddar S, Parakh N, Chandra J, Seth A. Pubertal development and its determinants in adolescents with transfusion-dependent thalassemia. Indian Pediatr. 2021;58:611–6.

    PubMed  Google Scholar 

  7. Italia K, Jijina F, Merchant R, et al. Response to hydroxyurea in β thalassemia major and intermedia: Experience in western India. Clinica Chimica Acta. 2009;407:10–15.

    Article  CAS  Google Scholar 

  8. Chandra J, Parakh N, Sidharth, et al. Efficacy and safety of thalidomide in patients with transfusion-dependent thalassemia. Indian Pediatr. 2021;58:635–8.

    PubMed  Google Scholar 

  9. Motta I, Bou-Fakhredin R, Taher A, Cappellini M. Beta thalassemia: New therapeutic options beyond transfusion and iron chelation. Drugs. 2020;15:1–11.

    Google Scholar 

  10. Soni S. Gene therapies for transfusion-dependent β-thalassemia. Indian Pediatr. 2021;58:667–74.

    PubMed  Google Scholar 

  11. Colah R, Gorakshakar A, Nadkarni A, et al. Regional heterogeneity of beta-thalassemia mutations in the multiethnic Indian population. Blood Cells Mol Dis. 2009;42:241–6.

    Article  CAS  Google Scholar 

  12. Gupta V, Sharma P, Jora R, Amandeep M, Kumar A. Screening for thalassemia carrier status in pregnancy and pre-natal diagnosis. Indian Pediatr. 2015;52:808–9.

    PubMed  Google Scholar 

  13. Verma I, Saxena R, Kohli S. Past, present and future scenario of thalassaemic care and control in India. Indian J Med Res. 2011;134:507–21.

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Thalassemia Clinic, Nanavati Max Super Specialty Hospital, Mumbai, Maharashtra, India

    Rashid Merchant

Authors
  1. Rashid Merchant
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rashid Merchant.

Additional information

Funding

None

Competing interests

None stated.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Merchant, R. Management of Thalassemia: Blood and Beyond. Indian Pediatr 58, 609–610 (2021). https://doi.org/10.1007/s13312-021-2253-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13312-021-2253-z

Search

Navigation